CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance https://cnb.cx/4ups5SV
2026-05-04T18:14:58.768Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.